340B Advocacy Alliance Bulletin

HHS Issues Proposed Remedy for Its Unlawful 340B Payment Cuts from 2018 to 2022
Register for June 28 Informational Phone Call for 340B Alliance Members On June 28 at 3 p.m. ET.
AHA, others voice strong opposition to 340B proposals being considered by House E&C Committee
The House Energy and Commerce Subcommittee on Health yesterday advanced a series of health care bills, and voted to pass and send to the full committee a bill that would impose additional reporting requirements on hospitals that participate in the 340B Drug Pricing Program.
Deceptively branded as an effort to save the 340B program, a legislative campaign by the Pharmaceutical Research and Manufacturers of America, National Association of Community Health Centers and other groups to remove many hospitals, eligible drugs and patients from the 340B program “would only…
AHA slams group’s proposal that would hurt 340B Program The AHA today responded to a new group that includes the Pharmaceutical Research and Manufacturers of America, National Association of Community Health Centers and other organizations calling for legislative changes that would hurt the 340B…